Home >Current Issue

Volume: 9, Issue: 7, July, 2019
DOI: 10.7324/JAPS.2019.90712

Research Article

Insulin resistance and the severity of coronary artery disease based on obesity status in stable-angina patients: A cross-sectional analysis

Deepak Uppunda1, Ranjan Shetty1, Pragna Rao2, Abdul Razak1, Ajit Singh1, Sheetal Chauhan3, Husena Vadnagarwala4, Sridevi Prabhu5, Umesh Pai5

  Author Affiliations


The evaluation of coronary artery disease (CAD) concerning the metabolic status and body mass index (BMI) is poorly studied. This study was designed to observe the relationship between insulin resistance (IR) and the severity of CAD on the basis of the metabolic and phenotypic status in stable-angina patients. A cross-sectional study was conducted on 532 patients with stable angina and coronary angiogram was done to diagnose the CAD for all. Determination of metabolic obesity was done using the National Cholesterol Education Program-Adult Treatment Panel III criteria. Phenotypic obesity was defined as BMI ≥ 25 kg/m2. Homeostasis model assessment IR in correlation with the severity of CAD was measured using SYNTAX (TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries) Score. The average age of the patients was 57.58 ± 10.40 years, and 69.4% were males. Out of 532 subjects, 51.3% were hypertensive, 14.5% were smokers, 29.1% consumed alcohol, 49.3% were metabolically obese, and 50% were phenotypically obese. Increase in IR increased the risk of severity of CAD in metabolically obese subjects (OR = 2.51, p = 0.048). In the phenotypically obese group, the relationship between IR and the severity of CAD was not statistically significant (OR = −2.19, p = 0.08). The study concludes that the increased IR increases the risk of severity of CAD in metabolically obese subjects.


Metabolic obesity, SYNTAX score, coronary angiogram, diabetes mellitus, glycosylated hemoglobin.

Citation: Uppunda D, Shetty R, Rao P, Razak A, Singh A, Chauhan S, Vadnagarwala H, Prabhu S, Pai U. Insulin resistance and the severity of coronary artery disease based on obesity status in stable-angina patients: A cross-sectional analysis. J Appl Pharm Sci, 2019; 9(07):091–094.

Copyright: The Author(s). This is an open access article distributed under the Creative Commons Attribution Non-Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Aziz A, Wheatcroft S. Insulin resistance in Type 2 diabetes and obesity: implications for endothelial function. Expert Rev Cardiovasc Ther, 2011; 9(4):403-7. https://doi.org/10.1586/erc.11.20

Cook S, Weitzman M, Auinger P, Nguyen M, Dietz W. Prevalence of a metabolic syndrome phenotype in adolescents. Arch Pediatr Adolesc Med, 2003; 157(8):821. https://doi.org/10.1001/archpedi.157.8.821

Graner M, Syvänne M, Kahri J, Nieminen M, Taskinen M. Insulin resistance as predictor of the angiographic severity and extent of coronary artery disease. Ann Med, 2007; 39(2):137-44. https://doi.org/10.1080/07853890601083451

Kruszelnicka O, Surdacki A, Golay A. Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study. Cardiovasc Diabetol, 2013; 12(1):145. https://doi.org/10.1186/1475-2840-12-145

Mahabala C, Srinivasan M, Manjrekar P, Unnikrishnan B, Ullal A, Kamath P, Kotekar M. Correlation of severity of coronary artery disease with insulin resistance. North Am J Med Sci, 2013; 5(10):611. https://doi.org/10.4103/1947-2714.120799

Oliveira C, Mello M, Cintra I, Fisberg M. Obesidade e síndrome metabólica na infância e adolescência. Rev Nutr, 2004; 17(2):237-45. https://doi.org/10.1590/S1415-52732004000200010

Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Metabolic syndrome in urban Asian Indian adults-a population study using modified ATP III criteria. Diabetes Res Clin Pract, 2003; 60(3):199-204. https://doi.org/10.1016/S0168-8227(03)00060-3

Reaven G. Role of insulin resistance in human disease. Nutrition, 1997; 13(1):64. https://doi.org/10.1016/S0899-9007(96)00380-2

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998; 352(9131):837-53. https://doi.org/10.1016/S0140-6736(98)07019-6

Wallace T, Levy J, Matthews D. Use and Abuse of HOMA Modeling. Diabetes Care, 2004; 27(6):1487-95. https://doi.org/10.2337/diacare.27.6.1487

Weisell R. Body mass index as an indicator of obesity. Asia Pac J Clin Nutr, 2002; 11(s8):S681-4. https://doi.org/10.1046/j.1440-6047.11.s8.5.x

Zornitzki T, Ayzenberg O, Gandelman G, Vered S, Yaskil E, Faraggi D, Caspi A, Goland S, Shvez O, Schattner A, Knobler H. Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women. QJM, 2007; 100(9):575-81. https://doi.org/10.1093/qjmed/hcm066

Article Metrics

Similar Articles

Pharmacological and Pharmaceutical Profile of Valsartan: A Review
Nadeem Siddiqui, Asif Husain, Lakshita Chaudhry, M Shamsher Alam, Moloy Mitra, Parminder S. Bhasin